相关实验视频

Updated: May 22, 2025

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

通过cGAS-STING通路的激活,EBV增强了肝内胆管癌的免疫疗法灵敏度

Lingli Huang^1,2,3,4, Qian Zhong^2,3,4,5, Silan Huang^1,2,3,4

¹VIP Department, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.

Hepatology communications

|March 13, 2025

概括

新的细胞系揭示了与爱斯坦-巴尔病毒相关的肝内胆管癌 (EBVaICC) 增强了免疫性. 这一发现为EBVaICC患者的免疫治疗敏感性改善提供了洞察力.

科学领域:

在瘤学瘤学.
病毒学病毒学
免疫学免疫学免疫学

背景情况:

埃普斯坦-巴尔病毒相关的肝内胆管癌 (EBVaICC) 缺乏代表性的细胞系,阻碍了对这种癌症分子和免疫方面的研究.
了解EBVaICC对于开发向疗法和改善患者治疗结果至关重要.

研究的目的:

建立和验证新的EBV阳性肝脏内胆瘤 (ICC) 细胞系.
调查EBVaICC背后的分子和免疫机制.
探索EBV在增强ICC免疫治疗反应方面的潜力.

主要方法:

转移性胆管癌患者接受抗PD1治疗的回顾性审查,包括EBVaICC和非EBVaICC队列.
通过细胞对细胞感染开发和验证两种EBV阳性ICC细胞系 (RBE-EBV,HuH28-EBV).
转录组,生物信息学,体外,RT-qPCR和ELISA分析以评估免疫反应和EBV的作用.

主要成果:

与非EBVaICC患者相比,EBVaICC患者表现出优异的免疫反应和改善的生存结果.
已建立的EBV阳性ICC细胞系 (RBE-EBV,HuH28-EBV) 显示出稳定的EBV感染和对病毒重新激活的反应能力.
cGAS-STING通路的EBV激活导致MHC-I上调和CXCL10分泌,增强CD8+T细胞活性,并表明免疫治疗敏感性增加.

结论:

新型EBV阳性ICC细胞系为研究EBVaICC提供了有价值的模型.
具有EBV阳性的ICC通过cGAS-STING通路激活表现出增强的免疫性.
结果提供了有关 EBVaICC 免疫治疗敏感性改善的机制的见解.

更多相关视频

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...